Cargando…
Testing for cirrhosis
Cirrhosis can be suspected by a thorough clinical assessment, but compensated liver disease is often asymptomatic. Select investigations are therefore critical for identifying patients with advanced liver disease and cirrhosis Biomarkers and validated serum tests can evaluate liver damage and synthe...
Autores principales: | Gupta, Sidhartha, Walker, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671021/ https://www.ncbi.nlm.nih.gov/pubmed/35002032 http://dx.doi.org/10.18773/austprescr.2021.053 |
Ejemplares similares
-
Testing for COVID-19
por: Brischetto, Anna, et al.
Publicado: (2020) -
Testing for COVID-19: a 2023 update
por: Meumann, Ella M, et al.
Publicado: (2023) -
Haemodynamic or metabolic stimulation tests to reveal the renal functional response: requiem or revival?
por: De Moor, Bart, et al.
Publicado: (2018) -
Comparison of native and transplant kidney biopsies: diagnostic yield and complications
por: Whittier, William L, et al.
Publicado: (2018) -
Risk of percutaneous renal biopsy of native kidneys in the evaluation of acute kidney injury
por: Korbet, Stephen M, et al.
Publicado: (2018)